Skip to main content
BB Biotech AG logo

BB Biotech AG — Investor Relations & Filings

Ticker · BION ISIN · CH0027659793 LEI · 391200MBZQNPFHIVKO34 SW Financial and insurance activities
Filings indexed 267 across all filing types
Latest filing 2026-01-23 Earnings Release
Country CH Switzerland
Listing SW BION

BB Biotech AG is an investment company specializing in the fast-growing biotechnology market. With over 30 years of experience, it is one of the world's largest investors in this sector. The company's investment strategy focuses on a portfolio of publicly listed companies that are developing and commercializing novel drugs. These target companies are selected for their potential to create significant value for the healthcare system by addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
BB Biotech AG closes the 2025 fiscal year with a profit
Earnings Release Classification · 95% confidence The document is an 'Ad-hoc' announcement regarding preliminary unaudited financial results for the 2025 fiscal year. It explicitly states that the complete annual report will be published at a later date (February 20, 2026). Because it provides key highlights of financial performance (profit figures) rather than the full report, and is under 5,000 characters, it is classified as an Earnings Release (ER). FY 2025
2026-01-23 English
EQS-Adhoc: BB Biotech AG closes the 2025 fiscal year with a profit
Earnings Release Classification · 100% confidence The document is an 'Ad hoc announcement' regarding preliminary unaudited financial results for the 2025 fiscal year. It provides key highlights (profit figures) but explicitly states that the complete annual report will be published on a later date (February 20, 2026). As it is an initial announcement of financial results rather than the full report itself, it falls under the Earnings Release category. FY 2025
2026-01-23 English
EQS-Adhoc: BB Biotech AG mit Gewinn im Geschäftsjahr 2025
Earnings Release Classification · 95% confidence The document is an 'Ad hoc-Mitteilung' (Ad hoc announcement) regarding the preliminary financial results for the fiscal year 2025. It provides key highlights (profit of CHF 578 million) but explicitly states that the full annual report will be published at a later date (February 20, 2026). Given the document length (under 5,000 characters) and its nature as an initial announcement of financial results, it is classified as an Earnings Release (ER). FY 2025
2026-01-23 German
EQS-News: BB Biotech: Preliminary full-year 2025 results and dividend proposal
Earnings Release Classification · 100% confidence The document is a press release titled 'BB Biotech: Preliminary full-year 2025 results and dividend proposal'. It provides key financial highlights, performance metrics, and a dividend proposal for the fiscal year 2025. It explicitly states that the full Annual Report will be published on February 20, 2026, confirming this document is an initial announcement of results rather than the full report itself. Therefore, it is classified as an Earnings Release (ER). FY 2025
2026-01-23 English
EQS-News: BB Biotech: Vorläufige Jahresergebnisse 2025 und Dividendenvorschlag
Earnings Release Classification · 100% confidence The document is a press release titled 'Vorläufige Jahresergebnisse 2025 und Dividendenvorschlag' (Preliminary Annual Results 2025 and Dividend Proposal). It provides key financial highlights, performance metrics, and a dividend proposal for the upcoming AGM. It explicitly states that the full annual report will be published at a later date (February 20, 2026). As this is an initial announcement of financial results (key highlights only) rather than the full annual report, it is classified as an Earnings Release. FY 2025
2026-01-23 German
BB Biotech AG publishes its interim report
Report Publication Announcement Classification · 100% confidence The document is a short announcement (3,779 characters) stating that BB Biotech AG has published its interim report. It provides a link to the report rather than containing the full report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-10-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.